Welcome to our dedicated page for Nano Dimension SEC filings (Ticker: nndm), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
nano dimension (tase: nndm, nasdaq: nndm) is a leading additive manufacturing technology company. nano dimension is disrupting, shaping and defining the future of how electronics are made. with its unique 3d printing technologies, nano dimension is targeting the growing demand for electronic devices that require increasingly sophisticated features and rely on printed circuit boards (pcbs). demand for circuitry, including pcbs - which are the heart of every electronic device - covers a diverse range of industries, including consumer electronics, medical devices, defense, aerospace, automotive, iot and telecom. these sectors can all benefit greatly from nano dimension’s 3d printed electronics solutions for rapid prototyping and short-run manufacturing. our dragonfly multi-material 3d printer family uses proprietary conductive nano-silver inks along with matched dielectric inks to make in-house agile hardware development and multi-layer pcb a reality. imagine being able to innovate and exNano Dimension Ltd. reported a sale of 136,208 American Depositary Shares on
Oramed Pharmaceuticals Inc., a Delaware corporation, filed Amendment No. 1 to its Schedule 13D regarding Nano Dimension Ltd. Ordinary Shares. Oramed reports beneficial ownership of 10,942,087 Ordinary Shares, representing 5.2% of the class, based on 210,334,767 shares outstanding as of October 14, 2025.
On February 17 and 18, 2026, Oramed purchased an additional 1,425,000 Ordinary Shares in open market transactions for an aggregate of approximately $2,800,500, using general working capital. On February 19, 2026, Oramed sent a response letter to an affiliate of Nano Dimension, reiterating dissatisfaction with the issuer’s management and stating an intent to further engage on performance, strategic direction, shareholder value and governance.
Nano Dimension Ltd. adopted a shareholder rights plan designed to protect holders of its American Depositary Shares. The company entered into a Rights Agreement with The Bank of New York Mellon, issuing one special purchase right for each ADS outstanding at the close of business on February 13, 2026.
Each Right lets its holder buy one ADS from the company at a purchase price of $0.01 per ADS if any person or group becomes an “Acquiring Person” by beneficially owning 9.99% or more of the company’s ordinary shares, subject to detailed exceptions. Rights held by an Acquiring Person or its affiliates are void.
The Board can redeem all Rights for no consideration before anyone becomes an Acquiring Person, or later exchange exercisable Rights for ADSs at a fixed ratio, subject to limits. The Rights expire on February 1, 2027. The Board states the plan is intended to give it time to evaluate any attempt to gain significant influence and to encourage negotiations it deems in the company’s best interests.
Oramed Pharmaceuticals Inc. and its CEO Nadav Kidron filed a Schedule 13D reporting beneficial ownership of 10,549,430 Nano Dimension ordinary shares, equal to 5.0% of the class based on 210,334,767 shares outstanding as of October 14, 2025.
They invested approximately $18,247,072 to build this position, with most shares held by Oramed and 135,700 shares held personally by Mr. Kidron. The filers state they have been, and expect to continue, discussing Nano Dimension’s performance, financing options, strategy, governance, and board composition with management, directors and other shareholders, and may propose changes, pursue additional share purchases or sales, hedging transactions, or potential corporate actions depending on future circumstances.
Nano Dimension Ltd. filed a current report to share that it has issued a press release with select preliminary financial results for its fiscal fourth quarter ended December 31, 2025. The company is providing an early view of its recent operating performance, but the detailed figures appear in the accompanying press release rather than in the body of the report.
The press release is attached as Exhibit 99.1 and is treated as “furnished,” not “filed,” which means it is not subject to certain liability provisions of U.S. securities laws and is not automatically incorporated into other registration statements or reports unless specifically referenced. This filing is primarily a disclosure mechanism to make those preliminary results broadly available to the market.
Nano Dimension Ltd. (NNDM) submitted a Form 6-K as a foreign private issuer to furnish a shareholder letter dated November 20, 2025. The letter, filed as Exhibit 99.1, accompanies proxy materials that were previously furnished on October 21, 2025. This Form 6-K is also incorporated by reference into Nano Dimension’s existing registration statements on Form F-3 and Form S-8, so it becomes part of those offering documents from the submission date.
Nano Dimension Ltd. furnished a new report as a foreign private issuer on Form 6-K, providing investors with access to its press release titled “Nano Dimension Announces Financial Results for Third Quarter 2025”.
The company attached this press release as Exhibit 99.1 and made its Financial Results, Forward-Looking Statements, and related GAAP financial statements part of several existing registration statements on Form F-3 and Form S-8. This step formally links the latest quarterly financial information to those registration statements for U.S. investors.
Nano Dimension (NNDM) furnished a shareholder letter on Form 6‑K to accompany proxy materials for its 2025 Annual General Meeting of Shareholders. The meeting is scheduled for December 4, 2025 at 5:00 p.m. Israel time (10:00 a.m. EST) at 60 Tower Road, Waltham, MA, and will also be held virtually.
The report is incorporated by reference into the company’s shelf and equity compensation registration statements on Forms F‑3 and S‑8. The shareholder letter is furnished as Exhibit 99.1.
Nano Dimension (NNDM) furnished a Form 6-K announcing its 2025 Annual General Meeting of Shareholders, scheduled for December 4, 2025. Shareholders of record at the close of business on October 14, 2025 are entitled to notice and to vote.
The filing includes a press release, Notice of Meeting, Proxy Statement, and Proxy Card, and is incorporated by reference into the company’s registration statements on Forms F-3 and S-8. The communication states it is not an offer or solicitation to buy or sell securities.
Nano Dimension Ltd. (NNDM) furnished a Form 6‑K noting a press release titled “Nano Dimension Announces Chief Financial Officer Transition” dated October 21, 2025. The press release is attached as Exhibit 99.1.
This report is incorporated by reference into the company’s Form F‑3 and Form S‑8 registration statements listed therein. The filing indicates the company files annual reports on Form 20‑F and is signed by CEO David Stehlin.